Delivery Order SPE2DB20D7059-SPE2DB25FGSE2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,163.02 to AmerisourceBergen Drug Corp for the supply of MICARDIS HCT 40-12.5 mg tablets in unit dose packaging (30 count) on September 2, 2025, with completion expected by September 3, 2025. This contract was awarded on a non-competitive, firm fixed-price basis and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion through...
- The Defense Logistics Agency awarded a delivery order valued at $3,631.02 to AmerisourceBergen Drug Corp for the supply of Micardis HCT 40-12.5 mg tablets in unit dose packaging (30 count) on August 11, 2025, with completion due by August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen Drug Corp's larger prime indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,933.79 to AmerisourceBergen Drug Corp for the supply of Micardis HCT 40-12.5 mg tablets (30 unit dose packages) with a completion date of November 18, 2025. This competitively awarded, firm fixed price delivery order was issued without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,772.81 to AmerisourceBergen Drug Corp for Micardis HCT 40-12.5 mg tablets (30-count unit dose packaging) with a completion deadline of September 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $1,243.66 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Micardis HCT 40-12.5 mg tablets (30 unit dose tablets). This competitively awarded, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed and delivered from the contractor's facility in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a $3,496.58 delivery order to AmerisourceBergen Drug Corp for MICARDIS HCT 80-25 mg tablets (30-count unit dose packaging) on November 25, 2025, with completion scheduled for November 26, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and specifies performance at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,073.28 to supply Micardis HCT 40-12.5 mg tablets (30-count unit dose packaging) with a completion date of December 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,118.25 to AmerisourceBergen Drug Corp for the supply of Micardis HCT 40-12.5 mg tablets (undivided 30-count packaging) with an ultimate completion date of November 25, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Micardis HCT 80-25 mg tablets in unit dose packages of 30 units. This firm fixed-price delivery order, valued at $1,889.91, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,407.34 to AmerisourceBergen Drug Corp for the supply of Micardis HCT 80-25 mg tablets (30-count unit dose packaging). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion on December 11, 2025. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGSE2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,416.12 to AmerisourceBergen Drug Corp for MICARDIS HCT 40-12.5 mg tablets (30-count unit dose packages) on September 15, 2025, with completion scheduled for September 16, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, leverages this prime indefinite delivery vehicle to supply an extensive portfolio of pharmaceutical products and medical supplies to support military healthcare programs and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. The company's federal contract award history demonstrates consistent capability in fulfilling diverse medical supply requirements through competitive procurement processes, with delivery orders typically structured as firm fixed-price agreements across a broad therapeutic range. This particular delivery order for MICARDIS HCT, an antihypertensive medication, exemplifies the routine pharmaceutical procurement conducted under AmerisourceBergen's DLA framework to support ongoing military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/15/25 |